| Breakdown | TTM | Nov 2025 | Nov 2024 | Nov 2023 | Nov 2022 | Nov 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 33.17B | 34.19B | 35.44B | 34.23B | 33.67B | 27.13B |
| Gross Profit | 2.92B | 3.39B | 5.50B | 5.94B | 7.20B | 5.54B |
| EBITDA | 2.41B | 2.88B | 4.97B | 5.55B | 6.87B | 5.22B |
| Net Income | 1.79B | 2.08B | 3.93B | 3.94B | 4.61B | 4.43B |
Balance Sheet | ||||||
| Total Assets | 33.21B | 34.43B | 41.31B | 39.23B | 37.98B | 33.21B |
| Cash, Cash Equivalents and Short-Term Investments | 2.09B | 3.80B | 4.98B | 6.56B | 4.79B | 2.93B |
| Total Debt | 4.32B | 6.32B | 4.45B | 5.14B | 6.36B | 6.54B |
| Total Liabilities | 11.18B | 12.29B | 13.29B | 12.53B | 13.74B | 12.21B |
| Stockholders Equity | 21.88B | 21.96B | 27.87B | 26.58B | 24.10B | 20.82B |
Cash Flow | ||||||
| Free Cash Flow | 14.77M | 28.18M | 2.23B | 5.08B | 3.21B | 2.47B |
| Operating Cash Flow | 177.35M | 216.81M | 2.40B | 5.18B | 3.27B | 2.53B |
| Investing Cash Flow | 178.81M | 221.57M | -302.56M | -176.98M | -128.30M | -105.09M |
| Financing Cash Flow | -549.37M | -1.60B | -3.68B | -3.25B | -1.28B | -2.40B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | $12.98B | 10.26 | 15.49% | 0.70% | 3.62% | -2.11% | |
72 Outperform | $41.60B | 13.31 | 13.24% | 1.14% | -5.57% | -19.40% | |
71 Outperform | $22.57B | 11.12 | 15.92% | 0.78% | -5.94% | -27.06% | |
67 Neutral | $17.02B | 14.16 | 32.66% | ― | -7.05% | -16.31% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | $3.27B | 9.27 | 9.01% | 1.76% | -13.61% | -37.18% | |
56 Neutral | $22.07B | 12.28 | 8.04% | 1.91% | -7.52% | -49.33% |